In April 2026, the MV Hondius set off from Patagonia. A few weeks later, this cruise raised concerns among health institutions in Europe, North America, Africa, Australia and New Zealand: Some passengers had developed severe hantavirus cardiopulmonary syndrome (HCPS), three of them died.1 The outbreak drew attention to the pathogen, which was previously mainly associated […]
Climate change, population growth, global travel and shifting lifestyles all increase both how likely and how quickly infectious diseases spread. This is especially true for arboviruses, which are vector-borne and include dengue virus, chikungunya virus and Oropouche virus. Oropouche fever in Brazil Brazil is a powerful example: Since the end of 2023, the incidence of
Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the previous portfolio primarily contained classic Euroimmun BIOCHIP Mosaics with different tissue sections as substrates, these new additions are highly relevant monospecific IFA with a particular focus
Currently, dengue fever poses the greatest challenge in terms of arbovirus infections. With over 14 million cases reported worldwide in 2024, this is the largest ever recorded epidemic of vector-borne viral diseases [1]. In Europe, 304 autochthonous cases were registered in the same year, representing a significant increase compared to 130 cases in 2023 and
With passion for rheumatology! The evaluation of the inflammatory status is crucial for the assessment of disease activity and therapy response in systemic autoimmune rheumatic diseases such as rheumatoid arthritis, systemic sclerosis, psoriasis arthritis or microscopic polyangiitis. A promising new biomarker in this context is the increasingly important inflammation parameter circulating calprotectin (cCALP). Calprotectin in
